Prospects for the control of neglected tropical diseases by mass drug administration (Q37557676)

21 August 2017

1 reference

title

Prospects for the control of neglected tropical diseases by mass drug administration (English)

1 reference

21 August 2017

Henk L Smits

1

1 reference

21 August 2017

1 February 2009

1 reference

Expert Review of Anti-infective Therapy

21 August 2017

1 reference

21 August 2017

7

1 reference

21 August 2017

37-56

1 reference

21 August 2017

1

1 reference

The neglected tropical diseases: the ancient afflictions of stigma and poverty and the prospects for their control and elimination

21 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Decision-model estimation of the age-specific disability weight for schistosomiasis japonica: a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Reconsidering the underestimated burden caused by neglected tropical diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Recent progress in integrated neglected tropical disease control

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Chemotherapy of schistosomiasis: present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Ivermectin: uses and impact 20 years on.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Towards the elimination of onchocerciasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Recent updates on onchocerciasis: diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Systemic antibiotics for communitywide trachoma control

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Mass treatment with single-dose azithromycin for trachoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Schistosomiasis, helminth infection and health education in Tanzania: achieving behaviour change in primary schools

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Factors influencing drug compliance in the mass drug administration programme against filariasis in the Western province of Sri Lanka

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Dracunculiasis--the saddle is virtually ended

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Measuring the burden of neglected tropical diseases: the global burden of disease framework

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Cost and cost-effectiveness of nationwide school-based helminth control in Uganda: intra-country variation and effects of scaling-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Double-blind placebo-controlled study of concurrent administration of albendazole and praziquantel in schoolchildren with schistosomiasis and geohelminths

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Assessments of pharmacokinetic drug interactions and tolerability of albendazole, praziquantel and ivermectin combinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Oral drug therapy for multiple neglected tropical diseases: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Efficacy and safety of drug combinations in the treatment of schistosomiasis, soil-transmitted helminthiasis, lymphatic filariasis and onchocerciasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Triple co-administration of ivermectin, albendazole and praziquantel in zanzibar: a safety study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Integrating an NTD with one of "The big three": combined malaria and trachoma survey in Amhara Region of Ethiopia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Prevention, control, and elimination of neglected diseases in the Americas: pathways to integrated, inter-programmatic, inter-sectoral action for health and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Age-dependent epidemiological patterns and strain diversity in helminth parasites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Aggregation and predisposition to Ascaris lumbricoides and Trichuris trichiura at the familial level

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Predisposition of individuals and families in Mexico to heavy infection with Ascaris lumbricoides and Trichuris trichiura

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Emerging Patterns of Hookworm Infection: Influence of Aging on the Intensity ofNecatorInfection in Hainan Province, People’s Republic of China

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Optimising the benefits of anthelmintic treatment in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Efficacy of current drugs against soil-transmitted helminth infections: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Reinfection with hookworm after chemotherapy in Papua New Guinea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Evidence for predisposition in humans to infection with Ascaris, hookworm, Enterobius and Trichuris in a South Indian fishing community.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

The effectiveness of 3, 5 or 7 days of albendazole for the treatment of Trichuris trichiura infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Efficacy of albendazole and its combinations with ivermectin or diethylcarbamazine (DEC) in the treatment of Trichuris trichiura infections in Sri Lanka.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Impact of a national helminth control programme on infection and morbidity in Ugandan schoolchildren

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Control of geohelminths by delivery of targeted chemotherapy through schools

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

A six-year follow-up of schoolchildren for urinary and intestinal schistosomiasis and soil-transmitted helminthiasis in Northern Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Effects of treatment for intestinal helminth infection on growth and cognitive performance in children: systematic review of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Micronutrient supplements for children after deworming

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Weekly iron and folic acid supplementation as a tool to reduce anemia among primary school children in Cambodia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Anthelminthic drug safety and drug administration in the control of soil-transmitted helminthiasis in community campaigns

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Use of benzimidazoles in children younger than 24 months for the treatment of soil-transmitted helminthiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

A double-blind randomized controlled trial of antenatal mebendazole to reduce low birthweight in a hookworm-endemic area of Peru

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Lack of risk of adverse birth outcomes after deworming in pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

The anthelminthic agent albendazole does not interact with p-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Monitoring drug efficacy and early detection of drug resistance in human soil-transmitted nematodes: a pressing public health agenda for helminth control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Drug resistance in veterinary helminths

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Specific interaction of benzimidazole anthelmintics with tubulin: high-affinity binding and benzimidazole resistance in Haemonchus contortus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Benzimidazole resistance in Haemonchus contortus is correlated with a conserved mutation at amino acid 200 in beta-tubulin isotype 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Molecular analysis of the beta-tubulin gene of human hookworms as a basis for possible benzimidazole resistance on Pemba Island

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Susceptibility to periportal (Symmers) fibrosis in human schistosoma mansoni infections: evidence that intensity and duration of infection, gender, and inherited factors are critical in disease progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

The pathobiology of Schistosoma haematobium infection in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Praziquantel for the treatment of schistosomiasis: its use for control in areas with endemic disease and prospects for drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Current status of sensitivity to praziquantel in a focus of potential drug resistance in Egypt

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Administration of praziquantel to pregnant and lactating women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Is praziquantel therapy safe during pregnancy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

The WHO dose pole for the administration of praziquantel is also accurate in non-African populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Observations on the effects of different chemotherapy strategies on the transmission of Schistosoma mansoni in Machakos District, Kenya, measured by long-term snail sampling and cercariometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Reinfection with Schistosoma haematobium following school-based chemotherapy with praziquantel in four highly endemic villages in Côte d'Ivoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Parasitological impact of 2-year preventive chemotherapy on schistosomiasis and soil-transmitted helminthiasis in Uganda.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Re-emerging schistosomiasis in hilly and mountainous areas of Sichuan, China

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Effects of the praziquantel-based control of schistosomiasis japonica in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Modeling the dynamics and control of Schistosoma japonicum transmission on Bohol island, the Philippines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Mathematical modelling of schistosomiasis japonica: comparison of control strategies in the People's Republic of China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

The global epidemiological situation of schistosomiasis and new approaches to control and research

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Chemotherapy for major food-borne trematodes: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

The histopathology of bancroftian filariasis revisited: the role of the adult worm in the lymphatic-vessel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Pathogenesis of filarial hydrocele: risk associated with intrascrotal nodules caused by death of adult Wuchereria bancrofti

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Lymphatic filariasis: an infection of childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

The role of albendazole in programmes to eliminate lymphatic filariasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Prolonged clearance of microfilaraemia in patients with bancroftian filariasis after multiple high doses of ivermectin or diethylcarbamazine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Single-dose treatment of wuchereria bancrofti infections with ivermectin and albendazole alone or in combination: Evaluation of the potential for control at 12 months after treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Treatment strategies underpinning the global programme to eliminate lymphatic filariasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

The impact of 34 years of massive DEC chemotherapy on Wuchereria bancrofti infection and transmission: the Maupiti cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

A 26-year follow-up of bancroftian filariasis in two communities in north-eastern Tanzania.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Elimination of bancroftian filariasis (Wuchereria bancrofti) in Santa Catarina state, Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Model-based analysis of trial data: microfilaria and worm-productivity loss after diethylcarbamazine-albendazole or ivermectin-albendazole combination therapy against Wuchereria bancrofti.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Mathematical models and lymphatic filariasis control: monitoring and evaluating interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Advances and challenges in predicting the impact of lymphatic filariasis elimination programmes by mathematical modelling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Effectiveness of annual ivermectin treatment for Wuchereria bancrofti infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Unfulfilled potential: using diethylcarbamazine-fortified salt to eliminate lymphatic filariasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Modes of action of anthelmintic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Detection of codon for amino acid 200 in isotype 1 beta-tubulin gene of Wuchereria bancrofti isolates, implicated in resistance to benzimidazoles in other nematodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Population genetics of concurrent selection with albendazole and ivermectin or diethylcarbamazine on the possible spread of albendazole resistance in Wuchereria bancrofti.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Vector control complements mass drug administration against bancroftian filariasis in Tirukoilur, India

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Incidence of blindness during the Onchocerciasis control programme in western Africa, 1971-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Association between microfilarial load and excess mortality in onchocerciasis: an epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Successful control of onchocerciasis with community-based ivermectin distribution in the Rio Santiago focus in Ecuador.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Impact of long-term treatment of onchocerciasis with ivermectin in Ecuador: potential for elimination of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

The Onchocerciasis Control Programme in West Africa (OCP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

The Onchocerciasis Elimination Program for the Americas (OEPA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

The achievements and challenges of the African Programme for Onchocerciasis Control (APOC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Periodic reproduction of Onchocerca volvulus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Impact of ivermectin on onchocerciasis transmission: assessing the empirical evidence that repeated ivermectin mass treatments may lead to elimination/eradication in West-Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Immunocompetence may be important in the effectiveness of Mectizan (ivermectin) in the treatment of human onchocerciasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Adverse systemic reactions to treatment of onchocerciasis with ivermectin at normal and high doses given annually or three-monthly

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

An investigation of persistent microfilaridermias despite multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Thirty-month follow-up of sub-optimal responders to multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Ivermectin imposes selection pressure on P-glycoprotein from Onchocerca volvulus: linkage disequilibrium and genotype diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Ivermectin selection on beta-tubulin: evidence in Onchocerca volvulus and Haemonchus contortus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Genetic selection of low fertile Onchocerca volvulus by ivermectin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Reduced genetic variation of an Onchocerca volvulus ABC transporter gene following treatment with ivermectin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Ivermectin resistance in Onchocerca volvulus: toward a genetic basis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

P-glycoprotein-like protein, a possible genetic marker for ivermectin resistance selection in Onchocerca volvulus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

What is the real target for ivermectin resistance selection in Onchocerca volvulus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Quantitative analysis of gender-regulated transcripts in the filarial nematode Brugia malayi by real-time RT-PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Identification and stage-specific expression of two putative P-glycoprotein coding genes in Onchocerca volvulus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

New strategies to combat filariasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Doxycycline as a novel strategy against bancroftian filariasis-depletion of Wolbachia endosymbionts from Wuchereria bancrofti and stop of microfilaria production

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Depletion of wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Assessment of microfilarial loads in the skin of onchocerciasis patients after treatment with different regimens of doxycycline plus ivermectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Wolbachia endobacteria depletion by doxycycline as antifilarial therapy has macrofilaricidal activity in onchocerciasis: a randomized placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Macrofilaricidal activity after doxycycline treatment of Wuchereria bancrofti: a double-blind, randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Doxycycline reduces plasma VEGF-C/sVEGFR-3 and improves pathology in lymphatic filariasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Macrofilaricidal effect of 4 weeks of treatment with doxycycline on Wuchereria bancrofti

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Azithromycin in control of trachoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Effect of a single mass antibiotic distribution on the prevalence of infectious trachoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Feasibility of eliminating ocular Chlamydia trachomatis with repeat mass antibiotic treatments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Trachoma and ocular Chlamydia trachomatis were not eliminated three years after two rounds of mass treatment in a trachoma hyperendemic village

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Mass antibiotics for trachoma and the Allee effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Randomised controlled trial of single-dose azithromycin in treatment of trachoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

A critical review of the SAFE strategy for the prevention of blinding trachoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Participatory evaluations of trachoma control programmes in eight countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Re-emergence of Chlamydia trachomatis infection after mass antibiotic treatment of a trachoma-endemic Gambian community: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

A rationale for continuing mass antibiotic distributions for trachoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Chlamydial positivity of nasal discharge at baseline is associated with ocular chlamydial positivity 2 months following azithromycin treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Mass antibiotic treatment and community protection in trachoma control programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Impact of annual targeted treatment on infectious trachoma and susceptibility to reinfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Disappearance of trachoma from Western Nepal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Reduction of trachoma in a sub-Saharan village in absence of a disease control programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Reduction of trachoma in the absence of antibiotic treatment: evidence from a population-based survey in Malawi

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Risk factors for active trachoma and Chlamydia trachomatis infection in rural Ethiopia after mass treatment with azithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Risk factors for active trachoma in children and trichiasis in adults: a household survey in Amhara Regional State, Ethiopia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Comparison of annual and biannual mass antibiotic administration for elimination of infectious trachoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Impact of mass distribution of azithromycin on the antibiotic susceptibilities of ocular Chlamydia trachomatis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Genetic and culture-based approaches for detecting macrolide resistance in Chlamydia pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Mutations in a 23S rRNA gene of Chlamydia trachomatis associated with resistance to macrolides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Quantitative high-throughput screen identifies inhibitors of the Schistosoma mansoni redox cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Current status of vaccines for schistosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Genetic variation in immune function and susceptibility to human filariasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Towards a recombinant antigen vaccine against Onchocerca volvulus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Multiple Chlamydiaceae species in trachoma: implications for disease pathogenesis and control

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

CD8 cytotoxic T cells in cutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Manifestations, diagnosis, and treatment of Strongyloides stercoralis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Oral miltefosine for Indian visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

Bridges to sustainable tropical health

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.7.1.37

21 January 2018

Identifiers

DOI

10.1586/14787210.7.1.37

1 reference

21 August 2017

1 reference

PubMed ID

19622056